Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 [Phase 3]

View source ↗

Summary

Phase 3 study evaluating relamorelin in diabetic gastroparesis was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• Relamorelin (relamorelin)

Snippet

Sponsor: Allergan | Conditions: Gastroparesis, Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-08-06